A Study shows mutation-resistant antibodies with 269×affinity, a proof point for CEPI’s 100 Days Mission and closing ...
Many proteins have a complex architecture that enables biological functions. Molecules can bind to specific sites on a protein and alter its function. A team at HZB has now investigated the Nsp1 ...
In summer 2025, the SARS-CoV-2 JN.1 sublineage became dominant with more resistant variants, such as XFG, LP.8.1, and NB.1.8.1. COVID-19 mRNA boosters were therefore updated for the 2025–2026 season ...
Flu has overtaken covid in infections and hospitalizations during the winter respiratory virus season, and their virulence is ...
Harnessing the power of a single dose, this innovative vaccine offers a potent defense against both current and future COVID-19 threats. Study: A single-dose intranasal live-attenuated codon ...
It's been five years since COVID-19 was declared a global pandemic. As SARS-CoV-2 shifts to endemic status, questions about its future evolution remain. New variants of the virus will likely emerge, ...
CDC data show SARS-CoV-2 and RSV continue to impact younger children and older adults, with significant hospitalization and mortality rates across the US.
A Statistical Immune Correlates of Protection Model for Predicting Efficacy from Neutralizing Antibody Titers to Establish Immunobridging of Monoclonal Antibodies for Prevention of COVID-19” was publi ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results